Reliability and validity of the classification of death in general practice

The general practitioner in the Netherlands is solely responsible for assigning the natural causes of a patient's death when it occurs at home and for entering it on the certificate of death B, which is then forwarded to the CSO (Central Statistics Office). The CSO however, records the cause of death in the appropriate category of the ICD-9 of the WHO. The value of these data, therefore, depends upon the agreement between the general practitioner's cause of death and the CSO categories of causes of death. To assess the degree to which the CSO classification reflects the general practitioner's cause of death, form B from eight general practitioners practicing in Hoorn were compared with the classification of the CSO during a period of five years, 1979-83. There was a 65% (237/365) agreement between the classifications. Of the remaining 128 cases 68% (87/128) of the classification differences were caused by a wrongly described cause of death on the B certificate. In 32% (41/128) the classification rules of WHO made it hardly possible for the general practitioner to classify uncertain causes of death. The conclusions of this survey are that the quality of the statistics on causes of death will improve if the general practitioners are more careful with filling in the certificate of death B; the classification rules of the ICD-9 makes it possible to classify unknown causes of death; and if the certificate of death B becomes more 'user friendly'.     

Regional left ventricular function in the three main coronary artery territories at rest and during exercise

Summary Twenty consecutive patients (mean age 51.6 years) with persistent severe angina pectoris underwent aorto-coronary bypass surgery receiving an overall of 60 anastomosis. On an average, 9.4±1.5 months p.o. first pass radionuclide ventriculograms (18 to 24 mCi 99 m Technetium-Pertechnetate i.v.) were performed at rest and after excerise. Besides measurement of global ejection fraction (GEF), regional ejection fraction (REF) was assessed employing for the first time a new technique: each RAO-view of p.o. radionuclide left ventriculogram was subdivided into three regions according to supply of the three main coronary arteries and their branches as visualized on pre-operative coronary angiogram.GEF improved after maximum exercise in 13 cases by 8.1% points (from 50.4 to 58.5%), remained unchanged three times and decreased four times by 7.1 points (from 51.6 to 44.5%; all changesp<0.05).In completely revascularized regions (n=35) REF improved 24 times by 9.7 points (from 51.1 to 60.8%), did not differ from rest REF six times and decreased in three case by 7.3 points (from 48.6 to 41.3%; all changesp<0.05). Completely revascularized regions responded to exercise like normally perfused areas (increase 7.8 points (from 50.6 to 58.4%;n=7;p<0.05).REF deteriorated in incompletely revascularized regions (n=9) six times by 12.8 points (from 58.0 to 45.2%), remained unchanged twice and improved once by 4.5 points. Total group's REF decreased by 7.3 points (from 56.8 to 49.5%;p<0.05). Exercise REF of incompletely revascularized regions was highly significant inferior to that of completely revascularized regions (49.5 to 58.4%;p<0.01).GEF is a weighted balance of the three regional ejection fractions. The most important parameter is REF of LAD territory.     

Thoracic duct lymph and PEEP studies in anaesthetized dogs

PEEP impedes thoracic duct drainage (LF). This can be counteracted by a thoracic duct fistula. Consequently, lung oedema (LOE) should develop during PEEP more slowly with LF at atmospheric pressure (LF_AP) than with LF against jugular venous pressure (LF_JVP). In 12 anaesthetized dogs LOE was produced by Ringer's solution i.v. (2.5 ml/min per kg) for 6 h during PEEP (10 mmHg) with either LF_AP or LF_JVP. Ringer's+PEEP greatly increased aortic, pulmonary artery and wedge pressures, JVP, and cardiac output. Colloid osmotic pressures in plasma and lymph were drastically reduced, pulmonary effective filtration pressure (EFP) rose by about 20 mmHg. LF_JVP increased 7-fold, LF_AP about 19-fold, the respective loss of plasma proteins was 1.83 and 1.06 g/kg during 6 h. Thermal-dye extravascular lung water showed an increment of 68 with LF_JVP versus 43 l/h/g per mmHg with LF_AP. Final lung water content was at any EFP (12.8–31.9 mmHg) lower with LF_AP than with LF_JVP amounting 512 with LF_JVP versus 377 l/g/per mmHg with LF_AP. LF_AP decreased the development of LOE during PEEP by bypassing the PEEP-induced high JVP and thus facilitating the removal of interstitial fluid. It is hypothesized that a thoracic duct fistula might aid the treatment of patients with LOE due to ARDS and therefore requiring high levels of PEEP.     

Prospective patient-controlled analgesia quality assurance: one year's experience

The goal of this project was to develop a prospective patient-controlled analgesia (PCA) quality assurance (QA) program and evaluate its impact on patient care. Initial elements selected for inclusion into the QA were: patient satisfaction, pain relief, clarity of instructions, respiratory rate, and nausea and vomiting. Standards were initially set at 100% with the exception of nausea and vomiting, which was 90%. Preliminary evaluation in 26 patients indicated initial standards were unrealistically high. Standards were revised to 90% for all elements except respiratory rate, which was left at 100%. Nausea and vomiting were eliminated from the QA because it was difficult to establish a cause and effect relationship with narcotic. Data were collected through patient interviews and chart reviews on a bimonthly basis. Cumulative data on 297 patients revealed standards were met in all categories. Two systematic problems identified early in the QA were that there was no recording of respiratory rate and there was a high incidence of unclear instructions. As a result of pharmacist interventions, outcomes improved. Patient outcomes with PCA therapy can be improved using a prospective PCA QA program. Pharmacy Department's without resources for daily monitoring of PCA patients should consider implementing a prospective PCA QA program.     

Lactose-derived oligosaccharides in the milk of elephants: comparison with human milk

Human milk is commonly considered to be unique when compared with the milk of other species with regard to its high content of complex fucosylated and sialylated lactose-derived oligosaccharides. We describe the application of high-pH anion-exchange chromatography with pulsed amperometric detection and TLC to characterize and quantitate neutral and sialylated lactose-derived oligosaccharides in milk from three Asian elephants and human milk. The lactose contents of elephant and human milks were 25-30 g/l and about 66 g/l respectively, whereas total oligosaccharide concentration was about three times higher in elephant milk and comprised up to 40% (10% in human milk) of the carbohydrate content. The ratio neutral: acidic components was different in the milk of the two species; in elephant milk, the N-acetylneuraminic acid-containing oligosaccharides made up almost half of the total amount v. 30% in human milk. Most oligosaccharides in elephant milk were more fucosylated and/or sialylated compared with human milk components. By mild acid hydrolysis, fucose and N-acetylneuraminic acid were cleaved off from complex components, and this resulted in increased amounts of fucose, galactose, N-acetylneuraminic acid, lactose and lacto-N-neo-tetraose. Unique to elephant milk are the high levels of 3'-galactosyllactose (up to 4 g/l) and lacto-N-neo-tetraose which are present in human milk only in trace amounts. Elephant and human milks have high levels and unique patterns of oligosaccharides which may reflect the relative importance of these components in neonatal host defence, in endothelial leucocyte interactions or in brain development.     

Noncontact detection of ocular melanoma withl-3-123I-Iodo-α-methyltyrosine: First clinical results

The results of the first clinical trial are presented of the newly designed tumor-seeking radiopharmaceuticall-3-¹²³I-iodo--methyltyrosine (IMT) for noncontact detection of malignant eye melanoma by means of a nuclear medicine technique. Eye scintigraphy (ES) was performed on ten outpatients clinically suspected of harboring an intraocular melanoma. ES was carried out with a twin pinhole eye collimator attached to a high resolution gamma camera; 7–10 mCi of IMT was given intravenously to each patient 100–150 min prior to the nuclear medicine investigation. Gamma camera eye scintigraphy and the use of IMT offer a useful noninvasive alternative to the radiophosphorus uptake test. Of the ten patients, five were found not to have a melanoma either clinically or by scintigraphy, three had a melanoma by scintigraphy that was confirmed histologically, and two yielded inconclusive results.

---

Zusammenfassung Die erste klinische Anwendung des neuen Radiopharmakonsl-3-¹²³-I-Iodo--Methyltyrosin (IMT) zum nuklearmedizinischen Nachweis des malignen Augen-Melanoms wird dargestellt. Es wurden 10 Poliklinik-Patienten mit Verdacht auf ein Melanom des Auges untersucht. Die Augen-Szintigraphie (ES) wird mit einem Zwillings-Lochblenden-Kollimator an einer Gamma-Kamera durchgeführt. 7–10 mCi IMT werden 100–150 min vor der Untersuchung i.v. appliziert. Die Augen-Szintigraphie mit Hilfe einer Gamma-Kamera unter Verwendung des Radiopharmakons IMT eröffnet eine brauchbare, nicht-invasive Untersuchungsmethode als Alternative zum Radiophosphor-Test. Von 10 untersuchten Patienten ließen sich 5 Fälle zusammenfassen, die weder klinisch, noch szintigraphisch ein Melanom hatten. Bei 3 Patienten ließ sich ein Augenmelanom eindeutig nachweisen und histopathologisch bestätigen. Bei 2 Patienten ergaben sich nichtschlüssige Resultate.